Aminocaproic

   
Google
 
Web NewDrugInformation.com

Aminocaproic


Drug - Aminocaproic
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aminocaproic Acid
Multiple ingredients are in alphabetical order.

Strength - 500MG
The potency of the active ingredient(s), Aminocaproic Acid. May repeat for multiple part products.

Applicant - MIKART
The firm name holding legal responsibility for Aminocaproic. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075602
The FDA assigned number to Aminocaproic. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Aminocaproic. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 24, 2001
The date Aminocaproic was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Aminocaproic. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Aminocaproic is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mikart Inc
The full name of the firm holding legal responsibility for the new application of Aminocaproic.

Aminocaproic